ghk-cu cosmetic peptide GHK-CU – Research Peptide |
Description
Yes, administration route significantly influences optimal dosing frequency due to differences in absorption kinetics and plasma concentration profiles
Phase 3 trials are ongoing or recently completed
The FDA has not approved these compounded medications and they are not the same as commercially manufactured drugs that have undergone FDA approval
A concentration this high is achieved at the peak of the Ca 2+ gradient in the granular layer of the epidermis (Elias et al., 2002
